The Tessa Jowell Brain Cancer Mission (TJBCM) has awarded six new centres excellence status including the East of England service (Cambridge University Hospitals, Norfolk and Norwich University Hospital and Ipswich Hospital).
Med-tech start-up 52 North Health has raised £1 million in its first round of funding to help it develop the NeutroCheck, a fully-integrated clinical, AI and medical device-based system for people living with cancer.
Cognitive impairment as a result of severe COVID-19 is similar to that sustained between 50 and 70 years of age and is the equivalent to losing 10 IQ points, say a team of scientists from the University of Cambridge and Imperial College London.
DNA analysis of thousands of tumours from NHS patients has found a ‘treasure trove’ of clues about the causes of cancer, with genetic mutations providing a personal history of the damage and repair processes each patient has been through.
A drug used to treat epilepsy patients could help prevent stroke in people whose arteries show signs of atherosclerosis – furring of the arteries – scientists will tell audiences at the Cambridge Festival.
Neurosurgery experts from Cambridge have led the largest ever study examining the surgical management of traumatic brain injuries, highlighting regional inequalities in both major causes and treatment of such injuries.
Meet the young biotech entrepreneur with two companies to her name and a plan to revolutionise the way we manage our health.
Cambridge's Experimental Medicine Initiative, working with AstraZeneca and GSK, is training specialists who can work out at an earlier stage of clinical trials if a treatment is likely to succeed.
GE Healthcare, the University of Cambridge and Cambridge University Hospitals have agreed to collaborate on developing an application aiming to improve cancer care, with Cambridge providing clinical expertise and data to support GE Healthcare’s development and evaluation of an AI-enhanced application that integrates cancer patient data from multiple sources into a single interface.
When a team of doctors, scientists and engineers at Addenbrooke’s Hospital and the University of Cambridge placed an air filtration machine in COVID-19 wards, they found that it removed almost all traces of airborne SARS-CoV-2.
© 2026 University of Cambridge